Longshenrongfa Pharmaceutical Industry: The holding subsidiary has obtained the renewed "Drug Manufacturing License"
Longshenrongfa Pharmaceutical Industry announced that its holding subsidiary, Gansu Puan Pharmaceutical Co., Ltd., has completed the renewal procedures for the "Drug Manufacturing License" due to the application for the reduction of entrusted production related matters. On September 25, 2025, it received the renewed "Drug Manufacturing License" approved by the Gansu Provincial Drug Administration. The change in this "Drug Manufacturing License" is mainly due to Puan Pharmaceutical's application for the reduction of the entrusted production of the Xuanfei Zhike Decoction and has completed the change procedures in accordance with the law, which will not have a significant impact on production and operations
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments